How should an elevated lipoprotein(a) influence cardiovascular risk management?

• A. It negates the need for statin therapy.
• B. It indicates immediate antibiotic treatment.
• C. It signifies increased ASCVD risk and is relatively resistant to standard lipid-lowering therapy; focus on overall risk reduction.
• D. It is not clinically relevant.

Answer: (C)

Elevated lipoprotein(a) raises cardiovascular risk on top of other lipids and is not substantially reduced by standard lipid-lowering therapy like statins. This means the finding should alert you to a higher ASCVD risk, and you should manage it by lowering overall risk rather than expecting major Lp(a) reduction from routine lipid therapy. So the best approach is to continue strong risk reduction: optimize LDL-C with appropriate therapy, control blood pressure and glucose, promote smoking cessation, weight management, and healthy lifestyle, and consider additional or emerging treatments only within the context of a comprehensive risk plan.